Brief: Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025
01/07/2025 12:17
July 1 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O: VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT WITH TORII PHARMACEUTICAL TO LAUNCH GLOBAL PIVOTAL PHASE 3 CLINICAL TRIAL TO STUDY YCANTH® FOR THE TREATMENT OF COMMON WARTS VERRICA PHARMACEUTICALS INC - TO RECEIVE $8 MILLION MILESTONE PAYMENT IN JULY 2025 VERRICA PHARMACEUTICALS INC - TO RECEIVE $10 MILLION MILESTONE PAYMENT UPON YCANTH APPROVAL IN JAPAN VERRICA PHARMACEUTICALS INC - TORII TO FUND FIRST $40 MILLION OF GLOBAL STUDY COSTS Source text: ID:nGNX5TnDmB Further company coverage: VRCA.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data